These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Differences in metabolic network modulation between capsulotomy and deep-brain stimulation for refractory obsessive-compulsive disorder. Suetens K; Nuttin B; Gabriëls L; Van Laere K J Nucl Med; 2014 Jun; 55(6):951-9. PubMed ID: 24722531 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological and imaging evidence of sustained inhibition in limbic and frontal networks following deep brain stimulation for treatment refractory obsessive compulsive disorder. Park HR; Kim IH; Kang H; McCairn KW; Lee DS; Kim BN; Kim DG; Paek SH PLoS One; 2019; 14(7):e0219578. PubMed ID: 31323037 [TBL] [Abstract][Full Text] [Related]
10. Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: Towards an Individualized Approach. Senova S; Clair AH; Palfi S; Yelnik J; Domenech P; Mallet L Front Psychiatry; 2019; 10():905. PubMed ID: 31920754 [TBL] [Abstract][Full Text] [Related]
11. Distribution of electric field in patients with obsessive compulsive disorder treated with deep brain stimulation of the bed nucleus of stria terminalis. Naesström M; Johansson J; Hariz M; Bodlund O; Wårdell K; Blomstedt P Acta Neurochir (Wien); 2022 Jan; 164(1):193-202. PubMed ID: 34652518 [TBL] [Abstract][Full Text] [Related]
12. Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder. Dougherty DD; Chou T; Corse AK; Arulpragasam AR; Widge AS; Cusin C; Evans KC; Greenberg BD; Haber SN; Deckersbach T J Neurosurg; 2016 Nov; 125(5):1087-1093. PubMed ID: 26894459 [TBL] [Abstract][Full Text] [Related]
13. Deep brain stimulation for obsessive-compulsive disorder: subthalamic nucleus target. Chabardès S; Polosan M; Krack P; Bastin J; Krainik A; David O; Bougerol T; Benabid AL World Neurosurg; 2013; 80(3-4):S31.e1-8. PubMed ID: 22469523 [TBL] [Abstract][Full Text] [Related]
14. Use of differential stimulation of the nucleus accumbens and anterior limb of the internal capsule to improve outcomes of obsessive-compulsive disorder. Xiong B; Li B; Wen R; Gao Y; Gong F; Li D; Xu Y; Deng H; Xiao L; Yin S; Zhang W; Lozano AM; Wang W J Neurosurg; 2023 Nov; 139(5):1376-1385. PubMed ID: 37243560 [TBL] [Abstract][Full Text] [Related]
15. Deep brain stimulation in the treatment of obsessive-compulsive disorder. Blomstedt P; Sjöberg RL; Hansson M; Bodlund O; Hariz MI World Neurosurg; 2013 Dec; 80(6):e245-53. PubMed ID: 23044000 [TBL] [Abstract][Full Text] [Related]
16. Current status of deep brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. de Koning PP; Figee M; van den Munckhof P; Schuurman PR; Denys D Curr Psychiatry Rep; 2011 Aug; 13(4):274-82. PubMed ID: 21505875 [TBL] [Abstract][Full Text] [Related]
17. Pre-supplementary motor network connectivity and clinical outcome of magnetic stimulation in obsessive-compulsive disorder. Ji GJ; Xie W; Yang T; Wu Q; Sui P; Bai T; Chen L; Chen L; Chen X; Dong Y; Wang A; Li D; Yang J; Qiu B; Yu F; Zhang L; Luo Y; Wang K; Zhu C Hum Brain Mapp; 2021 Aug; 42(12):3833-3844. PubMed ID: 34050701 [TBL] [Abstract][Full Text] [Related]
18. Tractographic description of major subcortical projection pathways passing the anterior limb of the internal capsule. Corticopetal organization of networks relevant for psychiatric disorders. Coenen VA; Schlaepfer TE; Sajonz B; Döbrössy M; Kaller CP; Urbach H; Reisert M Neuroimage Clin; 2020; 25():102165. PubMed ID: 31954987 [TBL] [Abstract][Full Text] [Related]
19. Common and differential connectivity profiles of deep brain stimulation and capsulotomy in refractory obsessive-compulsive disorder. Chen X; Wang Z; Lv Q; Lv Q; van Wingen G; Fridgeirsson EA; Denys D; Voon V; Wang Z Mol Psychiatry; 2022 Feb; 27(2):1020-1030. PubMed ID: 34703025 [TBL] [Abstract][Full Text] [Related]
20. Patient-specific connectomic models correlate with, but do not reliably predict, outcomes in deep brain stimulation for obsessive-compulsive disorder. Widge AS; Zhang F; Gosai A; Papadimitrou G; Wilson-Braun P; Tsintou M; Palanivelu S; Noecker AM; McIntyre CC; O'Donnell L; McLaughlin NCR; Greenberg BD; Makris N; Dougherty DD; Rathi Y Neuropsychopharmacology; 2022 Mar; 47(4):965-972. PubMed ID: 34621015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]